Drug
Arbaclofen Placarbil
Arbaclofen Placarbil: highest development phase Phase 2, developed by Indivior. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| Arbaclofen Placarbil NCT02511886 | Phase 2 | Alcohol Use Disorder |
| Arbaclofen Placarbil SR NCT03058237 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Arbaclofen Placarbil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.